These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. 5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial. Vukotic R, Di Donato R, Roncarati G, Simoni P, Renzulli M, Gitto S, Schepis F, Villa E, Berzigotti A, Bosch J, Andreone P. J Hepatol; 2023 Oct; 79(4):977-988. PubMed ID: 37482222 [Abstract] [Full Text] [Related]
8. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis. Kim SG, Kim TY, Sohn JH, Um SH, Seo YS, Baik SK, Kim MY, Jang JY, Jeong SW, Lee B, Kim YS, Suk KT, Kim DJ. Am J Gastroenterol; 2016 Nov; 111(11):1582-1590. PubMed ID: 27575713 [Abstract] [Full Text] [Related]
9. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. González-Abraldes J, Albillos A, Bañares R, Del Arbol LR, Moitinho E, Rodríguez C, González M, Escorsell A, García-Pagán JC, Bosch J. Gastroenterology; 2001 Aug; 121(2):382-8. PubMed ID: 11487547 [Abstract] [Full Text] [Related]
14. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J. Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642 [Abstract] [Full Text] [Related]
15. Metformin reduces hepatic resistance and portal pressure in cirrhotic rats. Tripathi DM, Erice E, Lafoz E, García-Calderó H, Sarin SK, Bosch J, Gracia-Sancho J, García-Pagán JC. Am J Physiol Gastrointest Liver Physiol; 2015 Sep 01; 309(5):G301-9. PubMed ID: 26138461 [Abstract] [Full Text] [Related]
16. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events]. Castaño G, Viudez P, Sookoian S, Carlevaro O, Riccitelli M, Frider B. Gastroenterol Hepatol; 2000 Sep 01; 23(6):275-81. PubMed ID: 15324622 [Abstract] [Full Text] [Related]
18. The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis. Ryu SR, Yoo JJ, Kang SH, Jeong SW, Kim MY, Cho YK, Chang Y, Kim SG, Jang JY, Kim YS, Baik SK, Kim YJ, Park SY, Baymbajav B. Clin Mol Hepatol; 2021 Jan 01; 27(1):197-206. PubMed ID: 33317252 [Abstract] [Full Text] [Related]
20. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis. García-Pagán JC, Escorsell A, Feu F, Bandi JC, Moitinho E, Casado M, Bosch J, Rodés J. J Hepatol; 1996 Apr 01; 24(4):430-5. PubMed ID: 8738729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]